Results

Total Results: 1,544 records

Showing results for "drug".

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/delirium-research-protocol.pdf
    June 01, 2018 - Currently, there are no medications approved by the Food and Drug Administration for the prevention … antipsychotic drugs cannot be isolated. 7 Comparison • For KQ 1, we will include non-drug … • For KQ 2, we will include non-drug approaches to treating delirium, including placebo, active … Non-drug interventions will be categorized following the scheme developed by Oh and colleagues.19 … Does antipsychotic drug use increase the risk of long term mortality?
  2. S143 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s143.pdf
    October 01, 2007 - Chief among them is the indication for the drug—a patient must have the condition for which the drug … In a randomized drug trial, the allocation of subjects to treatment and control groups at random leads … Seeger, PharmD, DrPH, Ingenix i3 Drug Safety, 950 Winter Street, Suite 3800, Waltham, MA 02451. … by a text search for the drug name. … Drug treatment of lipid disorders. N Engl J Med. 1999;341: 498–511. 6.
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine_protocol-appendix_20111103.pdf
    November 03, 2011 - Pharmacological classes for migraine prevention Drug, ATC Code* Class of Drug ANTIEPILEPTICS … (continued) Source: www.effectivehealthcare.ahrq.gov Published Online: November 3, 2011 A-2 Drug … (continued) Source: www.effectivehealthcare.ahrq.gov Published Online: November 3, 2011 A-3 Drugdrug management.mp. 2. exp patient care team/ 3. exp delivery of health care, integrated/ 4. … drug surveillance.mp. 10. exp drug monitoring/ 11. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10
  4. S58 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s58.pdf
    October 01, 2007 - ORIGINAL ARTICLE Studying Prescription Drug Use and Outcomes With Medicaid Claims Data Strengths, Limitations … Prescription drug claims histories reflect complex and often erratic patterns of use over time. … availability to the patient, not actual drug-taking behavior. … Filled prescriptions, repre- senting a necessary, though not sufficient, condition for drug ingestion … Pharmacoepidemiol Drug Saf. 2003;12:103–111. 16. Crystal S, Sambamoorthi U, Walkup JT, et al.
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/indirect-comparisons_research.pdf
    March 01, 2013 - Food and Drug Administration, Center for Drug Evaluation and Research. … Food and Drug Administration, Center for Drug Evaluation and Research. … Food and Drug Administration, Center for Drug Evaluation and Research. … Food and Drug Administration, Center for Drug Evaluation and Research. … Food and Drug Administration, Center for Drug Evaluation and Research.
  6. effectivehealthcare.ahrq.gov/products/rheumatoid-arthritis-medicine/research
  7. #14 SUBSTANCE ABUSE (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1312.pdf
    December 01, 2013 - Opioid abuse is one of the most common forms of prescription drug abuse. … The company submitted a new drug application to the U.S. … Food and Drug Administration (FDA) in October 2012. … Anonymous and free prescription drug drop off program. [internet]. … Project Lazarus: an innovative community response to prescription drug overdose.
  8. effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1512.pdf
    December 01, 2015 - drug- name=orkambi. 14. Walker J. FDA panel backs Vertex cystic-fibrosis drug Orkambi. … drug-name=orkambi http://www.wsj.com/articles/fda-panel-backs-vertex-cystic-fibrosis-drug-orkambi-1431462559 … Policy #DRUG.00080. [internet]. … drug- name=pirfenidone. 71. Medica. … National drug list: drug list - three (3) tier drug plan.
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_policymaker.pdf
    August 01, 2016 - Food and Drug Administration for AUD include acamprosate (Campral®, thrice daily), disulfiram (Antabuse … Food and Drug Administration as treatment for alcohol dependence, alcohol abuse, or AUD.
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-193-naloxone-executive-summary.pdf
    November 01, 2017 - Food and Drug Administration. 2016 Meeting Materials, Anesthetic and Analgesic Drug Products Advisory … Joint meeting of the anesthetic and analgesic drug products advisory committee and the drug safety and … Joint meeting of the anesthetic and analgesic drug products and the drug safety and risk management … Food and Drug Administration. … Joint meeting of anesthetic and analgesic drug products advisory committee and drug safety and risk
  11. effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_espanol.pdf
    November 01, 2016 - � Acamprosato (Campral®): Este medicamento fue aprobado por la Food and Drug Administration (FDA,
  12. effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1412.pdf
    October 01, 2015 - the drug cost. … In November 2014, the company submitted a new drug application to the U.S. … Early success for Kalydeco is just the beginning for Vertex's CF drug. … Food and Drug Administration (FDA). … Vertex's two-drug cystic fibrosis treatment shows promise. [internet].
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0128_07-01-2009.pdf
    January 01, 2009 - Effective Health Care Topic Number: 0167 Document Completion Date: 1-11-10 1 Results of Topic Selection Process & Next Steps  Generic versus brand name antiepileptic drugs for the treatment of epilepsy will be addressed as part of a larger in-process systematic review on treatment of epilepsy t…
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-glucose-control_research.pdf
    July 01, 2010 - We evaluated whether early use of this drug was consistent with the FDA-approved indications for use … The dataset included patients with a diagnosis of DM, or a claim for a drug used to treat DM, between … (San Diego, CA), was approved by the FDA on April 28, 2005.2 Exenatide is a first-in-class drug that … If the patient had sufficient drug-on-hand for 2 Effective Health Care Program Research Report … Discussion The early users of this new drug (in the first six months since approval) were largely
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/misuse-adhd-prescription-rapid-research.pdf
    July 01, 2025 - in 2022, representing the primary drug for 31, secondary drug for 31, and tertiary drug for 16 admissions … For instance, the Drug Abuse Warning Network (DAWN), a national database tracking drug-related emergency … College Prescription Drug Study Key Findings Report. … Drug Abuse Warning Network (DAWN): National Estimates from Drug-Related Emergency Department Visits … Misuse”[Mesh] OR “Drug Misuse”[Mesh] OR “Prescription Drug Diversion”[Mesh] OR “Substance Abuse, Oral
  16. #14 SUBSTANCE ABUSE (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1406.pdf
    January 01, 2020 - Food and Drug Administration (FDA) bioequivalence study data were available for a drug or a pilot was … Narcan: FDA drug overview. [internet]. Silver Spring (MD): U.S. … Food and Drug Administration (FDA) [accessed 2014 May 05]. [2 p]. … Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER); 2014 Apr 3. … Holder urges use of drug to combat heroin overdoses.
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-medicine_executive.pdf
    April 01, 2012 - 1 Comparative Effectiveness Review Number 55 Drug Therapy for Rheumatoid Arthritis in Adults: An … The Key Questions (KQs) are as follows: KQ1: For patients with RA, do drug therapies differ in their … Hand searches were conducted on the Center for Drug Evaluation and Research (CDER) database of the … Our major findings are presented in this section by type of drug comparison for benefits and harms ( … Drug Therapy for Rheumatoid Arthritis in Adults: An Update.
  18. Ced -Appendix-2 (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/ced%20-appendix-2.xlsx
    May 29, 2025 - Application of CED to an on-label use of a drug or biological is contrary to the requirements of the … controlled trials (RTCs) and to incorporate real-world evidence (RWE) Exclude on-label use of Food and Drug … drugs and biologicals be excluded from CED restrictions Application of CED to an on-label use of a drug … Requirements for post-FDA-approval real-world evidence development that is based on coverage to label for any drug
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/epilepsy-medicine_surveillance.pdf
    August 01, 2012 - evaluations and one search capturing older versus newer antiepileptic drug evaluations. … Comparative efficacy of combination drug therapy in refractory epilepsy. … Antiepileptic drug combinations--have newer agents altered clinical outcomes? … Pharmacotherapy:The Journal of Human Pharmacology & Drug Therapy. 2012 Apr;32(4):314-22. … drug therapy.fs. 6. randomly.ab. 7. trial.ab. 8. groups.ab. 9.
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/epilepsy-medicine_surveillance.pdf
    August 01, 2012 - evaluations and one search capturing older versus newer antiepileptic drug evaluations. … Comparative efficacy of combination drug therapy in refractory epilepsy. … Antiepileptic drug combinations--have newer agents altered clinical outcomes? … Pharmacotherapy:The Journal of Human Pharmacology & Drug Therapy. 2012 Apr;32(4):314-22. … drug therapy.fs. 6. randomly.ab. 7. trial.ab. 8. groups.ab. 9.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: